This report provides a comprehensive analysis of the global household in vitro diagnostic market, projecting significant growth through 2032. Driven by an increasing trend toward self-monitoring, preventive healthcare, and the rising prevalence of chronic diseases, the market is expanding across various product types and applications, including infectious diseases and diabetes. The study offers detailed regional forecasts and evaluates key industry players, examining competitive strategies, technological innovations, and emerging opportunities within the evolving home-based diagnostic landscape.

Market Overview

The global Household in Vitro Diagnostic market size is predicted to grow from US$ 9695 million in 2025 to US$ 14930 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.

While most in vitro diagnostic (IVD) tests are typically conducted in clinical laboratories or healthcare settings, there are also some IVD devices designed for use in households. These tests are often intended for personal use, enabling individuals to monitor certain health parameters or conditions without the need for a healthcare professional's involvement.

Market Drivers and Trends

• Self-Monitoring and Preventive Healthcare: The market is driven by an increasing trend toward self-monitoring and preventive healthcare within households. Devices ranging from home pregnancy tests to blood glucose monitors empower individuals to assess various health parameters conveniently.
• Chronic Disease Prevalence: The growing prevalence of chronic diseases, coupled with a shift towards proactive health management, propels the adoption of in vitro diagnostic tools at the household level.
• Technological Innovation: The market benefits from continuous innovations that enhance the user-friendliness and accuracy of home diagnostic devices.
• Impact of COVID-19: The COVID-19 pandemic has further accelerated the acceptance of home-based diagnostics, contributing to the market's expansion as individuals seek accessible and immediate health information within the comfort of their homes.

Report Scope and Methodology

LPI (LP Information)' newest research report, the “Household in Vitro Diagnostic Industry Forecast,” reviews total world Household in Vitro Diagnostic sales in 2025 and provides a comprehensive analysis of projected sales for 2026 through 2032 by region and market sector. This report provides a detailed analysis in US$ millions of the world Household in Vitro Diagnostic industry, including breakdowns by region, market sector, and sub-sector.

This Insight Report provides a comprehensive analysis of the global Household in Vitro Diagnostic landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyses the strategies of leading global companies, focusing on their Household in Vitro Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating global market.

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook and breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory of the global Household in Vitro Diagnostic market. It presents a comprehensive overview, market shares, and growth opportunities by product type, application, key players, and key regions and countries.

Market Segmentation

By Type

• Consumables
• Equipment

By Application

• Infectious Disease
• Diabetes
• Other

By Geography

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

The following companies have been profiled based on inputs gathered from primary experts and analyses of company coverage, product portfolios, and market penetration:

• Roche
• Siemens
• Abbott
• Danaher
• Thermo Fisher
• BioMerieux
• Bio-Rad
• BD
• KHB
• Daan Gene
• Leadman
• Zhongsheng
• Bsbe
• Maccura
• Hitachi
• Canon
• Sysmex
• Auto Bio
• Mindray
• Bgi
• Wondfo

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Household in Vitro Diagnostic Market Size (2021-2032)

    • 2.1.2 Household in Vitro Diagnostic Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Household in Vitro Diagnostic by Country/Region (2021, 2025 & 2032)

  • 2.2 Household in Vitro Diagnostic Segment by Type

    • 2.2.1 Consumables

    • 2.2.2 Equipment

    • 2.2.3 Household in Vitro Diagnostic Market Size by Type

      • 2.2.3.1 Household in Vitro Diagnostic Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.3.2 Global Household in Vitro Diagnostic Market Size Market Share by Type (2021-2026)

  • 2.3 Household in Vitro Diagnostic Segment by Application

    • 2.3.1 Infectious Disease

    • 2.3.2 Diabetes

    • 2.3.3 Other

    • 2.3.4 Household in Vitro Diagnostic Market Size by Application

      • 2.3.4.1 Household in Vitro Diagnostic Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.4.2 Global Household in Vitro Diagnostic Market Size Market Share by Application (2021-2026)

• 3 Household in Vitro Diagnostic Market Size by Player

  • 3.1 Household in Vitro Diagnostic Market Size Market Share by Player

    • 3.1.1 Global Household in Vitro Diagnostic Revenue by Player (2021-2026)

    • 3.1.2 Global Household in Vitro Diagnostic Revenue Market Share by Player (2021-2026)

  • 3.2 Global Household in Vitro Diagnostic Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Household in Vitro Diagnostic by Region

  • 4.1 Household in Vitro Diagnostic Market Size by Region (2021-2026)

  • 4.2 Global Household in Vitro Diagnostic Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Household in Vitro Diagnostic Market Size Growth (2021-2026)

  • 4.4 APAC Household in Vitro Diagnostic Market Size Growth (2021-2026)

  • 4.5 Europe Household in Vitro Diagnostic Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Household in Vitro Diagnostic Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Household in Vitro Diagnostic Market Size by Country (2021-2026)

  • 5.2 Americas Household in Vitro Diagnostic Market Size by Type (2021-2026)

  • 5.3 Americas Household in Vitro Diagnostic Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Household in Vitro Diagnostic Market Size by Region (2021-2026)

  • 6.2 APAC Household in Vitro Diagnostic Market Size by Type (2021-2026)

  • 6.3 APAC Household in Vitro Diagnostic Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Household in Vitro Diagnostic Market Size by Country (2021-2026)

  • 7.2 Europe Household in Vitro Diagnostic Market Size by Type (2021-2026)

  • 7.3 Europe Household in Vitro Diagnostic Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Household in Vitro Diagnostic by Region (2021-2026)

  • 8.2 Middle East & Africa Household in Vitro Diagnostic Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Household in Vitro Diagnostic Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Household in Vitro Diagnostic Market Forecast

  • 10.1 Global Household in Vitro Diagnostic Forecast by Region (2027-2032)

    • 10.1.1 Global Household in Vitro Diagnostic Forecast by Region (2027-2032)

    • 10.1.2 Americas Household in Vitro Diagnostic Forecast

    • 10.1.3 APAC Household in Vitro Diagnostic Forecast

    • 10.1.4 Europe Household in Vitro Diagnostic Forecast

    • 10.1.5 Middle East & Africa Household in Vitro Diagnostic Forecast

  • 10.2 Americas Household in Vitro Diagnostic Forecast by Country (2027-2032)

    • 10.2.1 United States Market Household in Vitro Diagnostic Forecast

    • 10.2.2 Canada Market Household in Vitro Diagnostic Forecast

    • 10.2.3 Mexico Market Household in Vitro Diagnostic Forecast

    • 10.2.4 Brazil Market Household in Vitro Diagnostic Forecast

  • 10.3 APAC Household in Vitro Diagnostic Forecast by Region (2027-2032)

    • 10.3.1 China Household in Vitro Diagnostic Market Forecast

    • 10.3.2 Japan Market Household in Vitro Diagnostic Forecast

    • 10.3.3 Korea Market Household in Vitro Diagnostic Forecast

    • 10.3.4 Southeast Asia Market Household in Vitro Diagnostic Forecast

    • 10.3.5 India Market Household in Vitro Diagnostic Forecast

    • 10.3.6 Australia Market Household in Vitro Diagnostic Forecast

  • 10.4 Europe Household in Vitro Diagnostic Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Household in Vitro Diagnostic Forecast

    • 10.4.2 France Market Household in Vitro Diagnostic Forecast

    • 10.4.3 UK Market Household in Vitro Diagnostic Forecast

    • 10.4.4 Italy Market Household in Vitro Diagnostic Forecast

    • 10.4.5 Russia Market Household in Vitro Diagnostic Forecast

  • 10.5 Middle East & Africa Household in Vitro Diagnostic Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Household in Vitro Diagnostic Forecast

    • 10.5.2 South Africa Market Household in Vitro Diagnostic Forecast

    • 10.5.3 Israel Market Household in Vitro Diagnostic Forecast

    • 10.5.4 Turkey Market Household in Vitro Diagnostic Forecast

  • 10.6 Global Household in Vitro Diagnostic Forecast by Type (2027-2032)

  • 10.7 Global Household in Vitro Diagnostic Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Household in Vitro Diagnostic Forecast

• 11 Key Players Analysis

  • 11.1 Roche

    • 11.1.1 Roche Company Information

    • 11.1.2 Roche Household in Vitro Diagnostic Product Offered

    • 11.1.3 Roche Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Roche Main Business Overview

    • 11.1.5 Roche Latest Developments

  • 11.2 Siemens

    • 11.2.1 Siemens Company Information

    • 11.2.2 Siemens Household in Vitro Diagnostic Product Offered

    • 11.2.3 Siemens Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Siemens Main Business Overview

    • 11.2.5 Siemens Latest Developments

  • 11.3 Abbott

    • 11.3.1 Abbott Company Information

    • 11.3.2 Abbott Household in Vitro Diagnostic Product Offered

    • 11.3.3 Abbott Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Abbott Main Business Overview

    • 11.3.5 Abbott Latest Developments

  • 11.4 Danaher

    • 11.4.1 Danaher Company Information

    • 11.4.2 Danaher Household in Vitro Diagnostic Product Offered

    • 11.4.3 Danaher Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Danaher Main Business Overview

    • 11.4.5 Danaher Latest Developments

  • 11.5 Thermo Fisher

    • 11.5.1 Thermo Fisher Company Information

    • 11.5.2 Thermo Fisher Household in Vitro Diagnostic Product Offered

    • 11.5.3 Thermo Fisher Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Thermo Fisher Main Business Overview

    • 11.5.5 Thermo Fisher Latest Developments

  • 11.6 BioMerieux

    • 11.6.1 BioMerieux Company Information

    • 11.6.2 BioMerieux Household in Vitro Diagnostic Product Offered

    • 11.6.3 BioMerieux Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 BioMerieux Main Business Overview

    • 11.6.5 BioMerieux Latest Developments

  • 11.7 Bio-Rad

    • 11.7.1 Bio-Rad Company Information

    • 11.7.2 Bio-Rad Household in Vitro Diagnostic Product Offered

    • 11.7.3 Bio-Rad Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Bio-Rad Main Business Overview

    • 11.7.5 Bio-Rad Latest Developments

  • 11.8 BD

    • 11.8.1 BD Company Information

    • 11.8.2 BD Household in Vitro Diagnostic Product Offered

    • 11.8.3 BD Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 BD Main Business Overview

    • 11.8.5 BD Latest Developments

  • 11.9 KHB

    • 11.9.1 KHB Company Information

    • 11.9.2 KHB Household in Vitro Diagnostic Product Offered

    • 11.9.3 KHB Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 KHB Main Business Overview

    • 11.9.5 KHB Latest Developments

  • 11.10 Daan Gene

    • 11.10.1 Daan Gene Company Information

    • 11.10.2 Daan Gene Household in Vitro Diagnostic Product Offered

    • 11.10.3 Daan Gene Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Daan Gene Main Business Overview

    • 11.10.5 Daan Gene Latest Developments

  • 11.11 Leadman

    • 11.11.1 Leadman Company Information

    • 11.11.2 Leadman Household in Vitro Diagnostic Product Offered

    • 11.11.3 Leadman Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Leadman Main Business Overview

    • 11.11.5 Leadman Latest Developments

  • 11.12 Zhongsheng

    • 11.12.1 Zhongsheng Company Information

    • 11.12.2 Zhongsheng Household in Vitro Diagnostic Product Offered

    • 11.12.3 Zhongsheng Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Zhongsheng Main Business Overview

    • 11.12.5 Zhongsheng Latest Developments

  • 11.13 Bsbe

    • 11.13.1 Bsbe Company Information

    • 11.13.2 Bsbe Household in Vitro Diagnostic Product Offered

    • 11.13.3 Bsbe Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Bsbe Main Business Overview

    • 11.13.5 Bsbe Latest Developments

  • 11.14 Maccura

    • 11.14.1 Maccura Company Information

    • 11.14.2 Maccura Household in Vitro Diagnostic Product Offered

    • 11.14.3 Maccura Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 Maccura Main Business Overview

    • 11.14.5 Maccura Latest Developments

  • 11.15 Hitachi

    • 11.15.1 Hitachi Company Information

    • 11.15.2 Hitachi Household in Vitro Diagnostic Product Offered

    • 11.15.3 Hitachi Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 Hitachi Main Business Overview

    • 11.15.5 Hitachi Latest Developments

  • 11.16 Canon

    • 11.16.1 Canon Company Information

    • 11.16.2 Canon Household in Vitro Diagnostic Product Offered

    • 11.16.3 Canon Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.16.4 Canon Main Business Overview

    • 11.16.5 Canon Latest Developments

  • 11.17 Sysmex

    • 11.17.1 Sysmex Company Information

    • 11.17.2 Sysmex Household in Vitro Diagnostic Product Offered

    • 11.17.3 Sysmex Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.17.4 Sysmex Main Business Overview

    • 11.17.5 Sysmex Latest Developments

  • 11.18 Auto Bio

    • 11.18.1 Auto Bio Company Information

    • 11.18.2 Auto Bio Household in Vitro Diagnostic Product Offered

    • 11.18.3 Auto Bio Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.18.4 Auto Bio Main Business Overview

    • 11.18.5 Auto Bio Latest Developments

  • 11.19 Mindray

    • 11.19.1 Mindray Company Information

    • 11.19.2 Mindray Household in Vitro Diagnostic Product Offered

    • 11.19.3 Mindray Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.19.4 Mindray Main Business Overview

    • 11.19.5 Mindray Latest Developments

  • 11.20 Bgi

    • 11.20.1 Bgi Company Information

    • 11.20.2 Bgi Household in Vitro Diagnostic Product Offered

    • 11.20.3 Bgi Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.20.4 Bgi Main Business Overview

    • 11.20.5 Bgi Latest Developments

  • 11.21 Wondfo

    • 11.21.1 Wondfo Company Information

    • 11.21.2 Wondfo Household in Vitro Diagnostic Product Offered

    • 11.21.3 Wondfo Household in Vitro Diagnostic Revenue, Gross Margin and Market Share (2021-2026)

    • 11.21.4 Wondfo Main Business Overview

    • 11.21.5 Wondfo Latest Developments

• 12 Research Findings and Conclusion